Table 4.
Cervical cancer screening rates for the period 2018–2020.
| Characteristics | 2018 (n = 2759a) | 2019 (n = 2756a) | 2020 (n = 2743a) | 2019 versus 2018 | 2020 versus 2019 | ||||
|---|---|---|---|---|---|---|---|---|---|
| SR, %b | SR, %b | SR, %b | SE | SRR | 95% CI | SE | SRR | 95% CI | |
| Overall | 20.2 | 22.2 | 20.4 | 0.027 | 1.10 | 1.04–1.16 | 0.027 | 0.92 | 0.87–0.97 |
| Age group, years | |||||||||
| 20–29 | 9.9 | 14.0 | 13.0 | 0.063 | 1.41 | 1.25–1.60 | 0.063 | 0.93 | 0.82–1.05 |
| 30–39 | 20.6 | 27.1 | 24.3 | 0.065 | 1.32 | 1.16–1.49 | 0.067 | 0.89 | 0.79–1.02 |
| 40–49 | 26.3 | 26.6 | 23.1 | 0.059 | 1.01 | 0.90–1.14 | 0.061 | 0.87 | 0.77–0.98 |
| 50–59 | 24.6 | 25.9 | 23.9 | 0.059 | 1.05 | 0.94–1.18 | 0.059 | 0.92 | 0.82–1.04 |
| 60–69 | 19.5 | 19.8 | 21.4 | 0.068 | 1.02 | 0.89–1.17 | 0.069 | 1.08 | 0.95–1.24 |
| 70–74 | 12.2 | 15.6 | 13.1 | 0.104 | 1.28 | 1.04–1.57 | 0.087 | 0.83 | 0.70–0.99 |
| Residential area | |||||||||
| Metropolitan | 22.2 | 21.6 | 17.9 | 0.040 | 0.97 | 0.90–1.05 | 0.040 | 0.83 | 0.77–0.90 |
| Urban | 19.4 | 24.2 | 23.4 | 0.040 | 1.25 | 1.15–1.35 | 0.040 | 0.97 | 0.89–1.05 |
| Rural | 14.8 | 14.9 | 17.6 | 0.086 | 1.01 | 0.85–1.19 | 0.093 | 1.18 | 0.99–1.42 |
| Monthly household income ($) | |||||||||
| ≤ 3999 | 17.3 | 20.9 | 19.5 | 0.049 | 1.21 | 1.10–1.33 | 0.049 | 0.93 | 0.85–1.03 |
| 4000–6999 | 23.8 | 21.4 | 19.9 | 0.045 | 0.90 | 0.83–0.98 | 0.047 | 0.93 | 0.85–1.02 |
| ≥ 7000 | 18.9 | 24.1 | 21.5 | 0.047 | 1.27 | 1.16–1.40 | 0.045 | 0.89 | 0.82–0.97 |
| Education status | |||||||||
| Middle school or lower | 11.5 | 12.9 | 15.6 | 0.079 | 1.12 | 0.96–1.31 | 0.075 | 1.21 | 1.05–1.41 |
| High school | 22.0 | 23.2 | 21.2 | 0.040 | 1.05 | 0.97–1.14 | 0.040 | 0.92 | 0.85–0.99 |
| College or higher | 20.3 | 24.1 | 20.9 | 0.042 | 1.19 | 1.09–1.29 | 0.042 | 0.87 | 0.80–0.94 |
| Chronic diseasec | |||||||||
| No | 17.2 | 22.8 | 20.1 | 0.032 | 1.33 | 1.25–1.41 | 0.032 | 0.88 | 0.83–0.94 |
| Yes | 27.7 | 20.4 | 20.8 | 0.052 | 0.74 | 0.67–0.82 | 0.050 | 1.02 | 0.93–1.13 |
SR screening rate, SRR screening rate ratio, SE standard error, CI confidence interval.
aThe n value is the number of women eligible for cervical cancer screening (aged over 20 years); bSRs were defined as the proportion of screened women within the last 1 year; Weighting values from the Population and Housing Census were applied to calculate the SRs; cChronic disease, women who are diagnosed with any of following diseases: hypertension, diabetes, tuberculosis, hepatitis B, hepatitis C, liver cirrhosis, chronic gastritis, stomach/duodenal ulcers, polyps, benign breast diseases, uterine myoma, and hyperlipidemia.